Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

62.09
Delayed Data
As of Mar 31
 +1.14 / +1.87%
Today’s Change
32.02
Today|||52-Week Range
65.35
+41.50%
Year-to-Date
No recent news for Ultragenyx Pharmaceutical Inc.

Today’s Trading

Previous close60.95
Today’s open61.87
Day’s range60.33 - 65.35
Volume929,132
Average volume (3 months)339,406
Market cap$2.2B
Dividend yield--
Data as of 03/31/2015

Growth & Valuation

Earnings growth (last year)+84.87%
Earnings growth (this year)-0.78%
Earnings growth (next 5 years)+75.40%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MNKDMannkind Corp-0.13-2.44%
PTCTPTC Therapeutics Inc-4.00-6.17%
CBPOChina Biologic Produ...+3.11+3.37%
TSROTESARO Inc-0.26-0.45%
Data as of 4:14pm ET, 03/31/2015

Financials

Next reporting dateMay 11, 2015
EPS forecast (this quarter)-$0.55
Annual revenue (last year)$0.00
Annual profit (last year)-$59.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Emil D. Kakkis
CFO, SVP-Finance &
Investor Relations
Shalini Sharp
Corporate headquarters
Novato, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account